Pathogenic
(Oct 09, 2018)
(ClinGen HL ACMG Specifications v1)
Method: curation
(Autosomal recessive inheritance)
Affected status: unknown
Allele origin: germline
FDARecognizedDatabase
Accession: SCV000840538.4
First in ClinVar: Oct 21, 2018
Last updated: Dec 11, 2022
- Publications:
- PubMed (6)
PubMed: 19023448‚ 25133613‚ 26338283‚ 24853665‚ 25356976‚ 19737284
- Other databases
- https://erepo.clinicalgenome.org… https://erepo.clinicalgenome.org/evrepo/ui/interpretation/fe785bf9-af38-456e-83ed-6717335dbde4
Comment: The c.8559-2A>G has been detected in >4 patients with Usher syndrome who were compound heterozygous for the this variant in trans with a truncating variant … (more) The c.8559-2A>G has been detected in >4 patients with Usher syndrome who were compound heterozygous for the this variant in trans with a truncating variant (PM3_VS; PMID: 25356976, 19737284, 26338283, 19023448). Segregation data was also available for two reported families with Usher syndrome. In one family, the variant was identified in trans with a frameshift variant in two affected siblings, and four unaffected siblings were either heterozygous for a single variant or wild-type for both variants. In the second family, an unaffected sibling was heterozygous for a single variant (PP1_Strong, PMID: 19023448). RT-PCR analysis of cells from a patient carrying the variant revealed that the variant causes skipping of exon 43, resulting in a 41 amino acid deletion of the USH2A protein (PM4, PMID: 20596040) The allele frequency of the c.8559-2A>G variant in the USH2A gene is 0.046% (8/17232) of East Asian chromosomes by the Genome Aggregation Database ( http://gnomad.broadinstitute.org), which is a low enough frequency to award PM2_supporting based on the thresholds defined by the ClinGen Hearing Loss Expert Panel for autosomal recessive hearing loss and Usher syndrome (PM2_Supporting). Several patients reported to harbor this variant displayed clinical features of Usher syndrome (PP4; PMID: 25356976, 19737284, 26338283, 19023448). In summary, this variant meets criteria to be classified as pathogenic for autosomal recessive Usher syndrome based on the ACMG/AMP criteria applied, as specified by the Hearing Loss Expert Panel: PM4, PM3_VS, PP1_S, PP4, PM2_P. (less)
Pathogenic
(Apr 20, 2022)
(ACMG Guidelines, 2015)
Method: clinical testing
Retinitis pigmentosa 39
Affected status: unknown
Allele origin: unknown
Accession: SCV000893286.2
First in ClinVar: Mar 31, 2019
Last updated: Dec 31, 2022
- Publications:
- PubMed (1)
PubMed: 25741868
- pmc: 4544753 pmc: 4544753
- DOI: 10.1038/gim.2015.30 DOI: 10.1038/gim.2015.30
Pathogenic
(May 13, 2022)
(ACMG Guidelines, 2015)
Method: clinical testing
Affected status: unknown
Allele origin: germline
Accession: SCV003826086.2
First in ClinVar: Mar 04, 2023
Last updated: Feb 04, 2024
Pathogenic
(Sep 12, 2011)
(LMM Criteria)
Method: clinical testing
Affected status: not provided
Allele origin: germline
Accession: SCV000065626.6
First in ClinVar: May 03, 2013
Last updated: Aug 26, 2019
- Publications:
- PubMed (3)
Comment: The 8559-2A>G variant in USH2A has been reported in 6 Asian individuals with Ush er type 2 and was absent in 470 Asian control chromosomes … (more) The 8559-2A>G variant in USH2A has been reported in 6 Asian individuals with Ush er type 2 and was absent in 470 Asian control chromosomes (Dai 2008, Nakanishi 2 009). All of these probands were compound heterozygous. This variant is predicte d to cause abnormal splicing because the nucleotide substitution occurs in the i nvariant region of the splice consensus sequence. Furthermore, RT-PCR analysis o f cells from a patient carrying the variant revealed that the variant causes ski pping of exon 43, resulting in a 41 amino acid deletion of the USH2A protein (Na kanishi 2010). In summary, this variant meets our criteria to be classified as p athogenic. (less)
Number of individuals with the variant: 2
Pathogenic
(Mar 20, 2024)
(ACMG Guidelines, 2015)
Method: clinical testing
Affected status: unknown
Allele origin: unknown
Accession: SCV004208226.2
First in ClinVar: Dec 30, 2023
Last updated: Jun 17, 2024
Pathogenic
(Jan 19, 2017)
(EGL Classification Definitions 2015)
Method: clinical testing
Affected status: unknown
Allele origin: germline
Accession: SCV000700946.2
First in ClinVar: Apr 02, 2018
Last updated: Apr 02, 2018
- Publications:
- PubMed (3)
PubMed: 19023448‚ 25133613‚ 25356976
- Other databases
- http://www.egl-eurofins.com/emvc… http://www.egl-eurofins.com/emvclass/emvclass.php?approved_symbol=USH2A
Number of individuals with the variant: 2
Sex: mixed
Pathogenic
(Oct 19, 2018)
(Blueprint Genetics Variant Classification Scheme)
Method: clinical testing
Affected status: yes
Allele origin: germline
Accession: SCV001240783.1
First in ClinVar: Apr 18, 2020
Last updated: Apr 18, 2020
Comment:
My Retina Tracker patient
Pathogenic
(Jun 17, 2021)
(ACMG Guidelines, 2015)
Method: clinical testing
(Autosomal recessive inheritance)
Affected status: yes
Allele origin: germline
Accession: SCV001762245.1
First in ClinVar: Jul 30, 2021
Last updated: Jul 30, 2021
Clinical Features:
Rod-cone dystrophy (present) , Hearing impairment (present)
Sex: female
Pathogenic
(Jan 03, 2022)
(ACMG Guidelines, 2015)
Method: clinical testing
Affected status: yes
Allele origin: germline
Accession: SCV002059155.1
First in ClinVar: Jan 15, 2022
Last updated: Jan 15, 2022
- Publications:
- PMID:19737284
- PMID:19737284
- PMID:19023448
- PMID:19023448
- PMID:25356976
- PMID:25356976
- PMID:26338283
- PMID:26338283
Comment: Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are … (more) Canonical splice site: predicted to alter splicing and result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region (PVS1_VS).The variant has been reported multiple times as an established pathogenic/likely pathogenic variant (ClinVar ID: VCV000048604, 3billion dataset). The variant was co-segregated with Usher syndrome, type 2A in multiple affected family members with additional meioses meeting strong evidence levels (PMID: 19023448, PP1_S). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000032, PM2_M). The same variant was previously reported several times in trans with another pathogenic variant in this gene (PMID: 19737284, 26338283, 25356976, 19023448, PM3_VS). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. (less)
Clinical Features:
Hearing impairment (present)
Pathogenic
(Nov 09, 2021)
(Myriad Women's Health Autosomal Recessive and X-Linked Classification Criteria (2021))
Method: clinical testing
Affected status: unknown
Allele origin: unknown
Accession: SCV002060359.2
First in ClinVar: Jan 15, 2022
Last updated: Nov 29, 2022
- Publications:
- PubMed (3)
PubMed: 25356976‚ 25324289‚ 20596040
Comment: NM_206933.2(USH2A):c.8559-2A>G is a canonical splice site variant classified as pathogenic in the context of USH2A-related disorders. c.8559-2A>G has been observed in cases with relevant disease … (more) NM_206933.2(USH2A):c.8559-2A>G is a canonical splice site variant classified as pathogenic in the context of USH2A-related disorders. c.8559-2A>G has been observed in cases with relevant disease (PMID: 25324289, 20596040, 25356976). Functional assessments of this variant are available in the literature (PMID: 20596040). c.8559-2A>G has been observed in population frequency databases (gnomAD: EAS 0.05%). In summary, NM_206933.2(USH2A):c.8559-2A>G is a canonical splice site variant that has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening. (less)
Pathogenic
(Jan 02, 2024)
(Invitae Variant Classification Sherloc (09022015))
Method: clinical testing
Affected status: unknown
Allele origin: germline
Accession: SCV000938861.6
First in ClinVar: Aug 14, 2019
Last updated: Feb 14, 2024
- Publications:
- PubMed (7)
PubMed: 16199547‚ 10729113‚ 10909849‚ 20507924‚ 25649381‚ 19023448‚ 19737284
Comment: This sequence change affects an acceptor splice site in intron 42 of the USH2A gene. It is expected to disrupt RNA splicing. Variants that disrupt … (more) This sequence change affects an acceptor splice site in intron 42 of the USH2A gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in USH2A are known to be pathogenic (PMID: 10729113, 10909849, 20507924, 25649381). This variant is present in population databases (rs397518039, gnomAD 0.05%). Disruption of this splice site has been observed in individuals with Usher syndrome (PMID: 19023448, 19737284). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 48604). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. (less)
Pathogenic
(Oct 01, 2023)
Method: research
Affected status: yes
Allele origin: germline
Accession: SCV004707924.1
First in ClinVar: Mar 10, 2024
Last updated: Mar 10, 2024
pathogenic
(-)
Method: not provided
Affected status: not provided
Allele origin: not provided
Accession: SCV000172669.1
First in ClinVar: Aug 08, 2014
Last updated: Aug 08, 2014
Comment:
Converted during submission to Pathogenic.
Pathogenic
(Feb 26, 2019)
Method: case-control
Affected status: yes
Allele origin: inherited
Accession: SCV000902401.1
First in ClinVar: May 13, 2019
Last updated: May 13, 2019
Number of individuals with the variant: 1
Clinical Features:
hearing loss (present)
Family history: yes
Pathogenic
(Sep 16, 2020)
Method: clinical testing
Affected status: unknown
Allele origin: germline
Accession: SCV001458111.1
First in ClinVar: Jan 02, 2021
Last updated: Jan 02, 2021